MedPath
FDA Approval

Onpattro

January 19, 2023

HUMAN PRESCRIPTION DRUG LABEL

Patisiran sodium(2 mg in 1 mL)

Manufacturing Establishments (2)

Alnylam Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

080889930

Ajinomoto Althea, Inc.

Alnylam Pharmaceuticals, Inc.

023050730

Products (1)

Onpattro

71336-1000

NDA210922

NDA (C73594)

INTRAVENOUS

January 19, 2023

MC-3Inactive
Code: Q0J6FQ6FKPClass: IACTQuantity: 13 mg in 1 mL
1,2-DIMYRISTOYL-SN-GLYCERO-3-CARBOXAMINOPROPYLPOLYETHYLENE GLYCOL 2000 METHYL ETHERInactive
Code: G739VUB5KOClass: IACTQuantity: 1.6 mg in 1 mL
Code: WO0YM16LKGClass: ACTIMQuantity: 2 mg in 1 mL
1,2-Distearoyl-sn-glycero-3-phosphocholineInactive
Code: 043IPI2M0KClass: IACTQuantity: 3.3 mg in 1 mL
Sodium ChlorideInactive
Code: 451W47IQ8XClass: IACTQuantity: 8.8 mg in 1 mL
MONOBASIC POTASSIUM PHOSPHATEInactive
Code: 4J9FJ0HL51Class: IACTQuantity: 0.2 mg in 1 mL
Sodium phosphate, dibasic, heptahydrateInactive
Code: 70WT22SF4BClass: IACTQuantity: 2.3 mg in 1 mL
WaterInactive
Code: 059QF0KO0RClass: IACT
CholesterolInactive
Code: 97C5T2UQ7JClass: IACTQuantity: 6.2 mg in 1 mL
© Copyright 2025. All Rights Reserved by MedPath